Koninklijke Philips (PHG) Consolidated Net Income (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Consolidated Net Income came in at $274.0 million in Q1 2026, up 4240.69% year-on-year from $6.3 million in Q1 2025, and up 5983.68% quarter-over-quarter from -$4.7 million in Q4 2025.
Koninklijke Philips (PHG) Consolidated Net Income (2009 - 2026) Analysis & Trends
Koninklijke Philips' Consolidated Net Income history runs 18 years deep, the most recent figure standing at $274.0 million for Q1 2026.
- On a quarterly basis, Consolidated Net Income rose 4240.69% year-over-year to $274.0 million in Q1 2026; TTM through Mar 2026 was $276.4 million, a 82.3% increase from a year earlier, with the FY2025 full-year figure at -$4.7 million, down 103.07% from the prior year.
- Consolidated Net Income grew to $274.0 million in Q1 2026 per PHG's latest filing, from -$4.7 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $453.1 million in Q4 2024 and bottomed at -$245.8 million in Q1 2022.
- The 5-year median for Consolidated Net Income is $1.1 million (2024), against an average of $10.7 million.
- Biggest YoY gain for Consolidated Net Income was 4311.06% in 2024; the steepest drop was 7072.07% in 2024.
- Year by year, Consolidated Net Income stood at $8.2 million in 2022, then plunged by 231.82% to -$10.8 million in 2023, then surged by 4311.06% to $453.1 million in 2024, then slumped by 101.03% to -$4.7 million in 2025, then jumped by 5983.68% to $274.0 million in 2026.
- Per Business Quant, the three latest PHG Consolidated Net Income figures stand at $274.0 million (Q1 2026), -$4.7 million (Q4 2025), and $9.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273.95 Mn |
| Dec 31, 2025 | -4.66 Mn |
| Sep 30, 2025 | 9.35 Mn |
| Jun 30, 2025 | -2.26 Mn |
| Mar 31, 2025 | 6.31 Mn |
| Dec 31, 2024 | 453.08 Mn |
| Sep 30, 2024 | -155.95 Mn |
| Jun 30, 2024 | -151.84 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | -10.76 Mn |
| Sep 30, 2023 | -7.62 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | -3.22 Mn |
| Dec 31, 2022 | 8.16 Mn |
| Sep 30, 2022 | 5.04 Mn |
| Jun 30, 2022 | 4.27 Mn |
| Mar 31, 2022 | -245.79 Mn |
| Dec 31, 2021 | 13.73 Mn |
| Sep 30, 2021 | 3.18 Bn |
| Jun 30, 2021 | -193.89 Mn |